|
2024
|
Invention
|
Cysteine-dependent inverse agonists of nuclear receptors ror-gamma/ror-gamma-t and methods of tre... |
|
|
Invention
|
Pyrazole and imidazole compounds for inhibition of il-17 and rorgamma.
Disclosed herein are comp... |
|
2023
|
Invention
|
Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock pro... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurological, neuromuscular, neuropsychiatric, p... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of
neurological, neuromuscular, neuropsychiatric, ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, mit... |
|
|
G/S
|
pharmaceutical preparations for the treatment of neurological, neuromuscular, neuropsychiatric, p... |
|
|
Invention
|
Co-crystal forms of a novobiocin analog and proline.
Disclosed are co-crystal forms of N-(2-(5-(... |
|
|
Invention
|
C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses.
Disclosed herein ... |
|
2022
|
G/S
|
Pharmaceutical preparations for the treatment of Friedreich ataxia |
|
|
Invention
|
Synthetic ursolic acid derivatives and methods of use thereof.
Disclosed herein are compounds of... |
|
|
Invention
|
Synthetic ursolic acid derivatives and methods of use thereof. Disclosed herein are compounds of ... |
|
|
Invention
|
Pyrimidine tricyclic enone derivatives for inhibition of ror-gamma and other uses. Disclosed here... |
|
2021
|
Invention
|
Synthetic triterpenoids for use in therapy. Provided are methods of administering synthetic tri t... |
|
|
Invention
|
Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators. Disclosed here... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of neurological disorders and degene... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment
of disorders of the nervous system,... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, ... |
|
|
Invention
|
Methods of treating covid-19 using bardoxolone methyl or analogs thereof. The present invention p... |
|
2020
|
Invention
|
C17-heteroaryl derivatives of oleanolic acid and methods of use thereof. Disclosed herein are nov... |
|
|
Invention
|
Synthetic triterpenoids with nitrogen-based substituents at c-17 and methods of use thereof.
In ... |
|
|
Invention
|
Synthetic triterpenoids with nitrogen-based substituents at c-17 and methods of use thereof. In s... |
|
|
G/S
|
Genetic identity tests comprised of reagents for medical
purposes. Genetic testing for medical p... |
|
|
G/S
|
Genetic identity tests comprised of reagents for medical purposes. Genetic testing for medical pu... |
|
|
Invention
|
C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof.
Disclos... |
|
|
Invention
|
C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof. Disclose... |
|
|
Invention
|
Co-crystal forms of a novobiocin analog and proline. Disclosed are co-crystal forms of N-(2-(5-((... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of disorders of the central and peri... |
|
|
G/S
|
Genetic identity tests comprised of reagents for medical purposes Genetic testing for medical pur... |
|
2019
|
Invention
|
Pyrazole and imidazole compounds for inhibition of il-17 and rorgamma. Disclosed herein are compo... |
|
|
Invention
|
Co-crystal forms of a novobiocin analog and proline. Di sclosed are co-crystal forms of N-(... |
|
2018
|
Invention
|
Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators.
Disclosed her... |
|
2017
|
Invention
|
Pyrimidine tricyclic enone derivatives for inhibition of ror.gamma. and other uses. Disclosed her... |
|
|
Invention
|
Pyrimidine tricyclic enone derivatives for inhibition of ror.gamma. and other uses. Disclos... |
|
|
Invention
|
Pyrimidine tricyclic enone derivatives for inhibition of rorγ and other uses. Disclosed herein ar... |
|
|
Invention
|
Methods of treating alport syndrome using bardoxolone methyl or analogs thereof. The present inve... |
|
|
Invention
|
Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use. ... |
|
|
Invention
|
C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof. Disclosed... |
|
2016
|
Invention
|
C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses. Disclosed herein a... |
|
|
Invention
|
Imidazolyl tricyclic enones as antioxidant inflammation modulators. Disclosed herein are compound... |
|
|
Invention
|
Imidazolyl tricyclic enones as antioxidant iflammation modulators. Disclosed herein are compounds... |
